Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in prevalence of retinal diseases, rising geriatric population, and advances in artificial retina.
The artificial retina market is segmented as below:
By Disease Type
- Macular degeneration
- Diabetic retinopathy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the artificial retina market covers the following areas:
- Artificial Retina Market sizing
- Artificial Retina Market forecast
- Artificial Retina Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global artificial retina market: Aetna Inc., Alcon Inc., Bausch Lomb Corp., Bionic Eye Technologies Inc., Bionic Vision Technologies, Carl Zeiss AG, Nano Retina, NIDEK Co. Ltd., Optobionics, and PIXIUM VISION.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is escalating investment in ophthalmological research and development and innovations."
According to the report, one of the major drivers for this market is the rise in prevalence of retinal diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aetna Inc.
- Alcon Inc.
- Bausch Lomb Corp.
- Bionic Eye Technologies Inc.
- Bionic Vision Technologies
- Carl Zeiss AG
- Nano Retina
- NIDEK Co. Ltd.
- Optobionics
- PIXIUM VISION